Osteoscreen Panel Test
Short Name: Osteoscreen Panel
Also known as: Bone Health Panel, Metabolic Bone Disease Panel, Bone Mineral Metabolism Panel, Osteoporosis Screening Panel
Osteoscreen Panel Test test available at DNA Labs India for ₹5,000. Uses CLIA (Chemiluminescence Immunoassay), Spectrophotometry on Serum samples. Results in Results are typically available within 24-48 hours from sample receipt at the laboratory. Reports are delivered via online portal, email, and WhatsApp.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Ramarao Paidisetty
Consultant Biochemist · Reg: 21504
Last reviewed: September 7, 2026
Overview
The Osteoscreen Panel Test is ordered to evaluate bone mineral metabolism and screen for metabolic bone disorders. It measures four key parameters—Calcium, Phosphorus, Intact PTH, and 25-Hydroxy Vitamin D—to assess the balance between bone formation and resorption. This panel helps diagnose conditions such as osteoporosis, osteomalacia, rickets, Paget's disease, hyperparathyroidism, and other disorders of bone metabolism. It is also used to monitor treatment response in patients already diagnosed with bone disorders and to evaluate mineral and vitamin deficiencies that may affect skeletal health.
- Test Code
- 1383
- ICD Code
- M80-M89
- Price
- ₹5,000
- Sample Type
- Serum
- Result Time
- Results are typically available within 24-48 hours from sample receipt at the laboratory. Reports are delivered via online portal, email, and WhatsApp.
- Fasting Required
- Yes
- Method
- CLIA (Chemiluminescence Immunoassay), Spectrophotometry
Sample Collection
Collect a preferably fasting blood sample between 8:00 AM and 10:00 AM. Avoid calcium or Vitamin D supplements for 24 hours prior unless advised otherwise by your physician. Inform your doctor about all medications you are currently taking.
Method: Venipuncture
Laboratory Analysis
A standard venipuncture will be performed to collect approximately 4 mL of blood into a Serum Separator Tube (SST). The procedure takes only a few minutes and involves minimal discomfort.
Report Delivery
After blood draw, slight bruising or soreness at the puncture site may occur and typically resolves within a day. You may resume normal activities, eating, and medication immediately after sample collection unless otherwise directed by your doctor.
Timeline: Results are typically available within 24-48 hours from sample receipt at the laboratory. Reports are delivered via online portal, email, and WhatsApp.
Patient Instructions
About This Test
Who Should Get This Test
The Osteoscreen Panel Test is ordered to evaluate bone mineral metabolism and screen for metabolic bone disorders. It measures four key parameters—Calcium, Phosphorus, Intact PTH, and 25-Hydroxy Vitamin D—to assess the balance between bone formation and resorption. This panel helps diagnose conditions such as osteoporosis, osteomalacia, rickets, Paget's disease, hyperparathyroidism, and other disorders of bone metabolism. It is also used to monitor treatment response in patients already diagnosed with bone disorders and to evaluate mineral and vitamin deficiencies that may affect skeletal health.
How to Prepare
- Fast for 8-10 hours before sample collection (water is permitted)
- Sample must be collected between 8:00 AM and 10:00 AM
- 4 mL blood collected in 1 SST (Serum Separator Tube)
- Separate serum within 30 minutes of collection
- Freeze the separated serum immediately after separation
- Ship the sample frozen. DO NOT THAW during transit
Doctor's Notes
Reviewed by Dr Ramarao Paidisetty — MBBS, MD (Biochemistry) · Reg. No. 21504
"The Osteoscreen Panel is an invaluable first-line screening tool for patients presenting with musculoskeletal complaints or risk factors for metabolic bone disease. By simultaneously evaluating calcium, phosphorus, PTH, and Vitamin D, this panel provides a holistic picture of bone mineral metabolism. Early identification of abnormalities—particularly subclinical Vitamin D deficiency or secondary hyperparathyroidism—enables timely intervention before irreversible bone loss occurs. I routinely recommend this panel for postmenopausal women, elderly individuals, patients on long-term corticosteroids, and anyone with a history of fragility fractures. Results should always be interpreted in the clinical context and may be supplemented with a DEXA scan for definitive osteoporosis diagnosis."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Hemolysed or lipemic samples
- Sample not separated and frozen within 30 minutes of collection
- Thawed samples during transit
- Samples collected outside the specified time window (8:00 AM – 10:00 AM)
- Insufficient sample volume (less than 2 mL serum)
- Improperly labelled or unlabeled samples
Understanding Your Results
This pattern commonly indicates Vitamin D deficiency with secondary hyperparathyroidism, often leading to osteomalacia in adults or rickets in children. Calcium absorption is impaired, and PTH rises to compensate by increasing bone resorption.
Recommendation: Vitamin D supplementation and dietary calcium correction. Further evaluation with DEXA scan recommended.
May suggest primary hyperparathyroidism where overactive parathyroid glands elevate PTH, causing calcium to be mobilized from bones. This can lead to osteoporosis over time.
Recommendation: Consult an endocrinologist. Parathyroid imaging and additional tests (ionized calcium, PTH repeat) may be required.
May indicate renal phosphate wasting disorders or oncogenic osteomalacia. Impaired phosphorus reabsorption leads to bone mineralization defects.
Recommendation: Further workup including renal function tests, FGF-23 levels, and referral to a specialist in metabolic bone disease.
Normal results suggest adequate bone mineral metabolism at the time of testing. However, this does not rule out structural bone abnormalities that require imaging (DEXA scan) for assessment.
Recommendation: Continue preventive measures including adequate calcium and Vitamin D intake, weight-bearing exercise, and periodic screening as advised by your doctor.
Consult your doctor if any of the Osteoscreen Panel parameters fall outside the normal reference range, or if you experience persistent bone or joint pain, frequent fractures, loss of height, or difficulty in mobility. Even if results are normal but symptoms persist, further evaluation including DEXA scan or additional bone turnover markers may be necessary. Pregnant women and individuals with chronic kidney disease should discuss results with their treating specialist.
Limitations
- ⚠This panel does not include markers of bone turnover such as CTx or P1NP
- ⚠Cannot replace DEXA scan for definitive bone mineral density assessment
- ⚠Results must be interpreted in clinical context alongside imaging and patient history
- ⚠Does not differentiate between bone-specific and non-bone sources of alkaline phosphatase
Risks & Considerations
- ●Minor bruising or swelling at the blood draw site
- ●Slight discomfort or pain during needle insertion
- ●Rare: dizziness or lightheadedness during blood collection
- ●Very rare: infection at the puncture site
Interfering Factors
- ●Recent intake of calcium or Vitamin D supplements may alter results
- ●Hemolysis in the blood sample can falsely elevate phosphorus levels
- ●Time of day of collection affects PTH levels (highest in early morning)
- ●Non-fasting samples may affect calcium and phosphorus readings
- ●Renal function impairment can independently affect all four parameters
- ●Certain medications such as diuretics, lithium, and antacids may influence results
Compare With Similar Tests
| Test | Osteoscreen Panel Test | DEXA Scan (Bone Densitometry) | Bone Profile Test | Alkaline Phosphatase (ALP) Test |
|---|---|---|---|---|
| Comparison | Osteoscreen Panel Test | DEXA measures bone mineral density (BMD) at specific sites and is the gold standard for osteoporosis diagnosis. The Osteoscreen Panel evaluates biochemical markers of bone metabolism. Both tests complement each other—Osteoscreen identifies metabolic causes while DEXA confirms structural bone loss. | A Bone Profile typically includes calcium, phosphorus, alkaline phosphatase, and albumin. The Osteoscreen Panel adds PTH and Vitamin D, offering a more comprehensive assessment of the hormonal regulation of bone metabolism. | ALP is a single marker of bone formation. The Osteoscreen Panel provides a broader picture by simultaneously assessing calcium, phosphorus, PTH, and Vitamin D, enabling identification of the underlying metabolic cause rather than just bone turnover activity. |
Frequently Asked Questions
What is the Osteoscreen Panel Test?
Why is the Osteoscreen Panel Test recommended?
What biomarkers are measured in the Osteoscreen Panel Test?
Do I need to fast before the Osteoscreen Panel Test?
What is the cost of the Osteoscreen Panel Test in India?
How is the sample collected for the Osteoscreen Panel Test?
What bone disorders can the Osteoscreen Panel Test detect?
How long does it take to get the Osteoscreen Panel Test results?
Who should get the Osteoscreen Panel Test done?
Is the Osteoscreen Panel Test covered under government health schemes?
What are the normal reference ranges for the Osteoscreen Panel Test?
Can the Osteoscreen Panel Test be done at home?
Related Tests
Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.